nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—artery—intracranial aneurysm	0.0227	0.0579	CbGeAlD
Nilotinib—TEK—artery—intracranial aneurysm	0.0131	0.0333	CbGeAlD
Nilotinib—EPHB2—brainstem—intracranial aneurysm	0.0121	0.0308	CbGeAlD
Nilotinib—MAPK8—brainstem—intracranial aneurysm	0.00965	0.0246	CbGeAlD
Nilotinib—EPHB3—brainstem—intracranial aneurysm	0.00796	0.0203	CbGeAlD
Nilotinib—CDC42BPB—medulla oblongata—intracranial aneurysm	0.00744	0.019	CbGeAlD
Nilotinib—CDC42BPB—midbrain—intracranial aneurysm	0.0068	0.0174	CbGeAlD
Nilotinib—MAPK8—medulla oblongata—intracranial aneurysm	0.00673	0.0172	CbGeAlD
Nilotinib—EPHA4—brainstem—intracranial aneurysm	0.00664	0.017	CbGeAlD
Nilotinib—MAPK8—midbrain—intracranial aneurysm	0.00615	0.0157	CbGeAlD
Nilotinib—MAPK14—brainstem—intracranial aneurysm	0.00613	0.0156	CbGeAlD
Nilotinib—EPHA8—cerebellum—intracranial aneurysm	0.0057	0.0146	CbGeAlD
Nilotinib—MAPK11—cerebellum—intracranial aneurysm	0.0053	0.0135	CbGeAlD
Nilotinib—CDC42BPB—cerebellum—intracranial aneurysm	0.00526	0.0134	CbGeAlD
Nilotinib—BRAF—midbrain—intracranial aneurysm	0.00511	0.0131	CbGeAlD
Nilotinib—HCK—medulla oblongata—intracranial aneurysm	0.0051	0.013	CbGeAlD
Nilotinib—EPHB2—brain—intracranial aneurysm	0.00483	0.0123	CbGeAlD
Nilotinib—MAPK8—cerebellum—intracranial aneurysm	0.00476	0.0121	CbGeAlD
Nilotinib—HCK—midbrain—intracranial aneurysm	0.00466	0.0119	CbGeAlD
Nilotinib—EPHA4—medulla oblongata—intracranial aneurysm	0.00463	0.0118	CbGeAlD
Nilotinib—EPHA8—brain—intracranial aneurysm	0.00463	0.0118	CbGeAlD
Nilotinib—CA7—midbrain—intracranial aneurysm	0.00456	0.0116	CbGeAlD
Nilotinib—MAP2K5—brainstem—intracranial aneurysm	0.00454	0.0116	CbGeAlD
Nilotinib—MAPK11—brain—intracranial aneurysm	0.00431	0.011	CbGeAlD
Nilotinib—CDC42BPB—brain—intracranial aneurysm	0.00427	0.0109	CbGeAlD
Nilotinib—CA14—medulla oblongata—intracranial aneurysm	0.00416	0.0106	CbGeAlD
Nilotinib—TIE1—cerebellum—intracranial aneurysm	0.00412	0.0105	CbGeAlD
Nilotinib—EPHB4—medulla oblongata—intracranial aneurysm	0.00405	0.0103	CbGeAlD
Nilotinib—EPHA3—brain—intracranial aneurysm	0.00405	0.0103	CbGeAlD
Nilotinib—KIT—brainstem—intracranial aneurysm	0.00403	0.0103	CbGeAlD
Nilotinib—BRAF—cerebellum—intracranial aneurysm	0.00395	0.0101	CbGeAlD
Nilotinib—EPHB3—cerebellum—intracranial aneurysm	0.00392	0.01	CbGeAlD
Nilotinib—TEK—medulla oblongata—intracranial aneurysm	0.00388	0.0099	CbGeAlD
Nilotinib—MAPK8—brain—intracranial aneurysm	0.00386	0.00987	CbGeAlD
Nilotinib—EPHA6—brain—intracranial aneurysm	0.00386	0.00987	CbGeAlD
Nilotinib—CA14—midbrain—intracranial aneurysm	0.0038	0.0097	CbGeAlD
Nilotinib—EPHB6—medulla oblongata—intracranial aneurysm	0.0037	0.00946	CbGeAlD
Nilotinib—EPHB4—midbrain—intracranial aneurysm	0.0037	0.00945	CbGeAlD
Nilotinib—ABL2—cerebellum—intracranial aneurysm	0.00358	0.00915	CbGeAlD
Nilotinib—LYN—brain—intracranial aneurysm	0.00357	0.00911	CbGeAlD
Nilotinib—TEK—midbrain—intracranial aneurysm	0.00354	0.00905	CbGeAlD
Nilotinib—CA7—cerebellum—intracranial aneurysm	0.00353	0.00901	CbGeAlD
Nilotinib—MAP4K1—brain—intracranial aneurysm	0.00351	0.00897	CbGeAlD
Nilotinib—ABL1—brainstem—intracranial aneurysm	0.0035	0.00895	CbGeAlD
Nilotinib—EPHB6—midbrain—intracranial aneurysm	0.00339	0.00865	CbGeAlD
Nilotinib—TIE1—brain—intracranial aneurysm	0.00335	0.00856	CbGeAlD
Nilotinib—EPHA4—cerebellum—intracranial aneurysm	0.00328	0.00837	CbGeAlD
Nilotinib—BRAF—brain—intracranial aneurysm	0.00321	0.0082	CbGeAlD
Nilotinib—EPHB3—brain—intracranial aneurysm	0.00319	0.00814	CbGeAlD
Nilotinib—MAP2K5—medulla oblongata—intracranial aneurysm	0.00317	0.00809	CbGeAlD
Nilotinib—CA9—cerebellum—intracranial aneurysm	0.0031	0.00791	CbGeAlD
Nilotinib—CSF1R—medulla oblongata—intracranial aneurysm	0.00309	0.0079	CbGeAlD
Nilotinib—MAPK14—cerebellum—intracranial aneurysm	0.00302	0.00772	CbGeAlD
Nilotinib—CA14—cerebellum—intracranial aneurysm	0.00294	0.00751	CbGeAlD
Nilotinib—HCK—brain—intracranial aneurysm	0.00293	0.00748	CbGeAlD
Nilotinib—ABL2—brain—intracranial aneurysm	0.00291	0.00743	CbGeAlD
Nilotinib—MAP2K5—midbrain—intracranial aneurysm	0.0029	0.0074	CbGeAlD
Nilotinib—CA4—brainstem—intracranial aneurysm	0.00288	0.00735	CbGeAlD
Nilotinib—CA7—brain—intracranial aneurysm	0.00287	0.00732	CbGeAlD
Nilotinib—EPHB4—cerebellum—intracranial aneurysm	0.00286	0.00731	CbGeAlD
Nilotinib—CSF1R—midbrain—intracranial aneurysm	0.00283	0.00722	CbGeAlD
Nilotinib—KIT—medulla oblongata—intracranial aneurysm	0.00281	0.00717	CbGeAlD
Nilotinib—PDGFRB—medulla oblongata—intracranial aneurysm	0.00274	0.007	CbGeAlD
Nilotinib—TEK—cerebellum—intracranial aneurysm	0.00274	0.007	CbGeAlD
Nilotinib—EPHA4—brain—intracranial aneurysm	0.00266	0.0068	CbGeAlD
Nilotinib—CA3—brain—intracranial aneurysm	0.00263	0.00671	CbGeAlD
Nilotinib—EPHB6—cerebellum—intracranial aneurysm	0.00262	0.00669	CbGeAlD
Nilotinib—KIT—midbrain—intracranial aneurysm	0.00257	0.00655	CbGeAlD
Nilotinib—PDGFRB—midbrain—intracranial aneurysm	0.00251	0.0064	CbGeAlD
Nilotinib—PDGFRA—cerebellum—intracranial aneurysm	0.00248	0.00634	CbGeAlD
Nilotinib—MAPK14—brain—intracranial aneurysm	0.00245	0.00627	CbGeAlD
Nilotinib—ABL1—medulla oblongata—intracranial aneurysm	0.00244	0.00624	CbGeAlD
Nilotinib—FGR—brain—intracranial aneurysm	0.00244	0.00624	CbGeAlD
Nilotinib—CA14—brain—intracranial aneurysm	0.00239	0.0061	CbGeAlD
Nilotinib—CA2—brainstem—intracranial aneurysm	0.00239	0.0061	CbGeAlD
Nilotinib—EPHB4—brain—intracranial aneurysm	0.00233	0.00594	CbGeAlD
Nilotinib—EPHA2—brain—intracranial aneurysm	0.00228	0.00583	CbGeAlD
Nilotinib—MAP2K5—cerebellum—intracranial aneurysm	0.00224	0.00572	CbGeAlD
Nilotinib—ABL1—midbrain—intracranial aneurysm	0.00223	0.00571	CbGeAlD
Nilotinib—TEK—brain—intracranial aneurysm	0.00223	0.00569	CbGeAlD
Nilotinib—CSF1R—cerebellum—intracranial aneurysm	0.00219	0.00558	CbGeAlD
Nilotinib—EPHB6—brain—intracranial aneurysm	0.00213	0.00543	CbGeAlD
Nilotinib—PDGFRA—brain—intracranial aneurysm	0.00202	0.00515	CbGeAlD
Nilotinib—CA4—medulla oblongata—intracranial aneurysm	0.00201	0.00513	CbGeAlD
Nilotinib—KIT—cerebellum—intracranial aneurysm	0.00198	0.00507	CbGeAlD
Nilotinib—PDGFRB—cerebellum—intracranial aneurysm	0.00194	0.00495	CbGeAlD
Nilotinib—CA12—brain—intracranial aneurysm	0.00186	0.00475	CbGeAlD
Nilotinib—CA4—midbrain—intracranial aneurysm	0.00183	0.00469	CbGeAlD
Nilotinib—MAP2K5—brain—intracranial aneurysm	0.00182	0.00465	CbGeAlD
Nilotinib—CSF1R—brain—intracranial aneurysm	0.00178	0.00454	CbGeAlD
Nilotinib—ABL1—cerebellum—intracranial aneurysm	0.00173	0.00441	CbGeAlD
Nilotinib—CA2—medulla oblongata—intracranial aneurysm	0.00166	0.00425	CbGeAlD
Nilotinib—KIT—brain—intracranial aneurysm	0.00161	0.00412	CbGeAlD
Nilotinib—PDGFRB—brain—intracranial aneurysm	0.00157	0.00402	CbGeAlD
Nilotinib—ABCG2—medulla oblongata—intracranial aneurysm	0.00154	0.00394	CbGeAlD
Nilotinib—CA2—midbrain—intracranial aneurysm	0.00152	0.00388	CbGeAlD
Nilotinib—CYP2D6—brainstem—intracranial aneurysm	0.00151	0.00387	CbGeAlD
Nilotinib—CA1—brain—intracranial aneurysm	0.00147	0.00377	CbGeAlD
Nilotinib—CA4—cerebellum—intracranial aneurysm	0.00142	0.00362	CbGeAlD
Nilotinib—ABCG2—midbrain—intracranial aneurysm	0.00141	0.0036	CbGeAlD
Nilotinib—ABL1—brain—intracranial aneurysm	0.0014	0.00358	CbGeAlD
Nilotinib—CA2—cerebellum—intracranial aneurysm	0.00118	0.00301	CbGeAlD
Nilotinib—CA4—brain—intracranial aneurysm	0.00115	0.00294	CbGeAlD
Nilotinib—ABCG2—cerebellum—intracranial aneurysm	0.00109	0.00278	CbGeAlD
Nilotinib—CA2—brain—intracranial aneurysm	0.000956	0.00244	CbGeAlD
Nilotinib—CYP2C8—brain—intracranial aneurysm	0.00091	0.00233	CbGeAlD
Nilotinib—ABCG2—brain—intracranial aneurysm	0.000885	0.00226	CbGeAlD
Nilotinib—CYP2B6—brain—intracranial aneurysm	0.000816	0.00209	CbGeAlD
Nilotinib—ABCB1—medulla oblongata—intracranial aneurysm	0.00076	0.00194	CbGeAlD
Nilotinib—CYP2D6—cerebellum—intracranial aneurysm	0.000747	0.00191	CbGeAlD
Nilotinib—ABCB1—midbrain—intracranial aneurysm	0.000695	0.00177	CbGeAlD
Nilotinib—CYP2D6—brain—intracranial aneurysm	0.000607	0.00155	CbGeAlD
Nilotinib—ABCB1—cerebellum—intracranial aneurysm	0.000537	0.00137	CbGeAlD
Nilotinib—EPHB2—Developmental Biology—MMP2—intracranial aneurysm	0.000518	0.000851	CbGpPWpGaD
Nilotinib—HCK—Immune System—CTSK—intracranial aneurysm	0.000516	0.000848	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CTSS—intracranial aneurysm	0.000513	0.000844	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CTSS—intracranial aneurysm	0.000508	0.000835	CbGpPWpGaD
Nilotinib—BLK—Immune System—CTSS—intracranial aneurysm	0.000508	0.000835	CbGpPWpGaD
Nilotinib—FGR—Immune System—CTSS—intracranial aneurysm	0.000507	0.000832	CbGpPWpGaD
Nilotinib—LCK—CXCR4-mediated signaling events—MMP9—intracranial aneurysm	0.000506	0.000831	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—MMP2—intracranial aneurysm	0.000503	0.000826	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CTSS—intracranial aneurysm	0.000503	0.000826	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—SLC25A16—intracranial aneurysm	0.000502	0.000824	CbGpPWpGaD
Nilotinib—EPHA6—Axon guidance—MMP9—intracranial aneurysm	0.000498	0.000818	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CTSS—intracranial aneurysm	0.000496	0.000815	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CTSK—intracranial aneurysm	0.000492	0.000809	CbGpPWpGaD
Nilotinib—KIT—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000488	0.000802	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CTSK—intracranial aneurysm	0.000482	0.000792	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CTSK—intracranial aneurysm	0.000479	0.000788	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—CTSB—intracranial aneurysm	0.000478	0.000785	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.000474	0.000779	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—AGER—intracranial aneurysm	0.000474	0.000778	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—MMP2—intracranial aneurysm	0.000473	0.000777	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—MMP9—intracranial aneurysm	0.000473	0.000777	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CTSK—intracranial aneurysm	0.000472	0.000776	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—NOS3—intracranial aneurysm	0.000471	0.000774	CbGpPWpGaD
Nilotinib—BLK—Immune System—CTSK—intracranial aneurysm	0.000468	0.000769	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CTSK—intracranial aneurysm	0.000468	0.000769	CbGpPWpGaD
Nilotinib—FGR—Immune System—CTSK—intracranial aneurysm	0.000466	0.000766	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CTSK—intracranial aneurysm	0.000463	0.00076	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000462	0.000759	CbGpPWpGaD
Nilotinib—EPHA2—Axon guidance—MMP9—intracranial aneurysm	0.000459	0.000755	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—CTSB—intracranial aneurysm	0.000459	0.000754	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CTSK—intracranial aneurysm	0.000457	0.00075	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—NCF1—intracranial aneurysm	0.000456	0.00075	CbGpPWpGaD
Nilotinib—ABL1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000452	0.000744	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—CTSB—intracranial aneurysm	0.000452	0.000743	CbGpPWpGaD
Nilotinib—HCK—Disease—CST3—intracranial aneurysm	0.000451	0.000742	CbGpPWpGaD
Nilotinib—ABCB1—brain—intracranial aneurysm	0.000436	0.00111	CbGeAlD
Nilotinib—EPHA2—Developmental Biology—MMP2—intracranial aneurysm	0.000436	0.000716	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—CTSB—intracranial aneurysm	0.000434	0.000713	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—NCF1—intracranial aneurysm	0.000432	0.00071	CbGpPWpGaD
Nilotinib—MAPK14—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000431	0.000708	CbGpPWpGaD
Nilotinib—MAPK8—Innate Immune System—AGER—intracranial aneurysm	0.000429	0.000705	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CTSS—intracranial aneurysm	0.000429	0.000705	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—AGER—intracranial aneurysm	0.000428	0.000703	CbGpPWpGaD
Nilotinib—HCK—Immune System—CTSB—intracranial aneurysm	0.000427	0.000702	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—SLC25A16—intracranial aneurysm	0.000426	0.0007	CbGpPWpGaD
Nilotinib—HCK—Immune System—NCF1—intracranial aneurysm	0.000425	0.000699	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—MMP9—intracranial aneurysm	0.000421	0.000692	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—MMP9—intracranial aneurysm	0.000421	0.000692	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000416	0.000684	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTSS—intracranial aneurysm	0.000412	0.000677	CbGpPWpGaD
Nilotinib—LYN—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000408	0.00067	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—CTSB—intracranial aneurysm	0.000407	0.000669	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—MMP9—intracranial aneurysm	0.000407	0.000668	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TIMP1—intracranial aneurysm	0.000406	0.000666	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTSS—intracranial aneurysm	0.000405	0.000665	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TIMP1—intracranial aneurysm	0.000404	0.000663	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—MMP9—intracranial aneurysm	0.000402	0.000661	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—MMP9—intracranial aneurysm	0.000402	0.000661	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CTSB—intracranial aneurysm	0.000399	0.000655	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CTSB—intracranial aneurysm	0.000397	0.000652	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CTSK—intracranial aneurysm	0.000395	0.000649	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000393	0.000646	CbGpPWpGaD
Nilotinib—HCK—Disease—NCF1—intracranial aneurysm	0.000392	0.000645	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—CTSB—intracranial aneurysm	0.000391	0.000643	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—MMP9—intracranial aneurysm	0.000389	0.00064	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—NCF1—intracranial aneurysm	0.000389	0.000639	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CTSB—intracranial aneurysm	0.000387	0.000636	CbGpPWpGaD
Nilotinib—BLK—Immune System—CTSB—intracranial aneurysm	0.000387	0.000636	CbGpPWpGaD
Nilotinib—FGR—Immune System—CTSB—intracranial aneurysm	0.000386	0.000634	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—NCF1—intracranial aneurysm	0.000385	0.000633	CbGpPWpGaD
Nilotinib—BLK—Immune System—NCF1—intracranial aneurysm	0.000385	0.000633	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TIMP1—intracranial aneurysm	0.000384	0.000632	CbGpPWpGaD
Nilotinib—FGR—Immune System—NCF1—intracranial aneurysm	0.000384	0.000631	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—CTSB—intracranial aneurysm	0.000383	0.000629	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—NCF1—intracranial aneurysm	0.000381	0.000626	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTSK—intracranial aneurysm	0.000379	0.000623	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—CTSB—intracranial aneurysm	0.000378	0.000621	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—MMP9—intracranial aneurysm	0.000378	0.000621	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTSK—intracranial aneurysm	0.000373	0.000612	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTSS—intracranial aneurysm	0.000365	0.0006	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—MMP9—intracranial aneurysm	0.000355	0.000584	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTSS—intracranial aneurysm	0.000346	0.000568	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—AGER—intracranial aneurysm	0.000342	0.000562	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTSK—intracranial aneurysm	0.000336	0.000552	CbGpPWpGaD
Nilotinib—LCK—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000334	0.000549	CbGpPWpGaD
Nilotinib—CA3—Metabolism—NOS3—intracranial aneurysm	0.000333	0.000547	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TIMP1—intracranial aneurysm	0.000332	0.000546	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ASAH1—intracranial aneurysm	0.000332	0.000546	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—MMP9—intracranial aneurysm	0.000328	0.000539	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CTSB—intracranial aneurysm	0.000327	0.000537	CbGpPWpGaD
Nilotinib—BRAF—Disease—CST3—intracranial aneurysm	0.000323	0.00053	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00032	0.000526	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTSK—intracranial aneurysm	0.000318	0.000523	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTSB—intracranial aneurysm	0.000314	0.000516	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—NCF1—intracranial aneurysm	0.000312	0.000513	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—SLC25A16—intracranial aneurysm	0.000312	0.000513	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTSS—intracranial aneurysm	0.000311	0.000512	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTSB—intracranial aneurysm	0.000308	0.000507	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—AGER—intracranial aneurysm	0.000308	0.000507	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—NCF1—intracranial aneurysm	0.000307	0.000504	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTSS—intracranial aneurysm	0.000305	0.000501	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—NOS3—intracranial aneurysm	0.000304	0.000499	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTSS—intracranial aneurysm	0.000303	0.000499	CbGpPWpGaD
Nilotinib—KIT—Disease—CST3—intracranial aneurysm	0.000294	0.000483	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—AGER—intracranial aneurysm	0.000292	0.00048	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTSS—intracranial aneurysm	0.000289	0.000475	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTSK—intracranial aneurysm	0.000287	0.000471	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.000282	0.000463	CbGpPWpGaD
Nilotinib—BRAF—Disease—NCF1—intracranial aneurysm	0.000281	0.000461	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTSK—intracranial aneurysm	0.000281	0.000461	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTSK—intracranial aneurysm	0.000279	0.000459	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—MMP2—intracranial aneurysm	0.000279	0.000458	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTSB—intracranial aneurysm	0.000278	0.000457	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—CST3—intracranial aneurysm	0.000278	0.000457	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—MMP2—intracranial aneurysm	0.000277	0.000456	CbGpPWpGaD
Nilotinib—KIT—Immune System—NCF1—intracranial aneurysm	0.000277	0.000455	CbGpPWpGaD
Nilotinib—HCK—Immune System—AGER—intracranial aneurysm	0.000276	0.000453	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTSK—intracranial aneurysm	0.000266	0.000437	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—SLC25A16—intracranial aneurysm	0.000264	0.000434	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—MMP2—intracranial aneurysm	0.000264	0.000434	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTSB—intracranial aneurysm	0.000263	0.000433	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—AGER—intracranial aneurysm	0.000263	0.000432	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—NCF1—intracranial aneurysm	0.000262	0.00043	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—AGER—intracranial aneurysm	0.000257	0.000423	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—AGER—intracranial aneurysm	0.000256	0.000421	CbGpPWpGaD
Nilotinib—KIT—Disease—NCF1—intracranial aneurysm	0.000255	0.00042	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—CST3—intracranial aneurysm	0.000251	0.000412	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—AGER—intracranial aneurysm	0.00025	0.000411	CbGpPWpGaD
Nilotinib—BLK—Immune System—AGER—intracranial aneurysm	0.00025	0.000411	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTSS—intracranial aneurysm	0.00025	0.000411	CbGpPWpGaD
Nilotinib—FGR—Immune System—AGER—intracranial aneurysm	0.000249	0.000409	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NCF1—intracranial aneurysm	0.000249	0.000409	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—AGER—intracranial aneurysm	0.000244	0.000401	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NCF1—intracranial aneurysm	0.000242	0.000397	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTSB—intracranial aneurysm	0.000237	0.00039	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NCF1—intracranial aneurysm	0.000237	0.000389	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—NCF1—intracranial aneurysm	0.000236	0.000388	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—EDNRA—intracranial aneurysm	0.000235	0.000386	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTSB—intracranial aneurysm	0.000232	0.000382	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTSB—intracranial aneurysm	0.000231	0.00038	CbGpPWpGaD
Nilotinib—LYN—Immune System—NCF1—intracranial aneurysm	0.000231	0.00038	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.00023	0.000378	CbGpPWpGaD
Nilotinib—ABL1—Immune System—NCF1—intracranial aneurysm	0.00023	0.000378	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTSK—intracranial aneurysm	0.00023	0.000378	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—EDNRA—intracranial aneurysm	0.000224	0.000367	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTSB—intracranial aneurysm	0.00022	0.000362	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NCF1—intracranial aneurysm	0.000219	0.00036	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NCF1—intracranial aneurysm	0.000218	0.000358	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	0.000217	0.000356	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.000215	0.000353	CbGpPWpGaD
Nilotinib—CA14—Metabolism—NOS3—intracranial aneurysm	0.000214	0.000352	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—AGER—intracranial aneurysm	0.000211	0.000347	CbGpPWpGaD
Nilotinib—LYN—Axon guidance—MMP9—intracranial aneurysm	0.000209	0.000344	CbGpPWpGaD
Nilotinib—CA6—Metabolism—NOS3—intracranial aneurysm	0.000209	0.000343	CbGpPWpGaD
Nilotinib—ABL1—Axon guidance—MMP9—intracranial aneurysm	0.000208	0.000343	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ASAH1—intracranial aneurysm	0.000207	0.00034	CbGpPWpGaD
Nilotinib—LCK—Disease—CST3—intracranial aneurysm	0.000201	0.00033	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—AGER—intracranial aneurysm	0.000199	0.000327	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—MMP2—intracranial aneurysm	0.000199	0.000327	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—MMP9—intracranial aneurysm	0.000199	0.000326	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NCF1—intracranial aneurysm	0.000198	0.000326	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MMP2—intracranial aneurysm	0.000198	0.000325	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NCF1—intracranial aneurysm	0.000197	0.000323	CbGpPWpGaD
Nilotinib—CA7—Metabolism—NOS3—intracranial aneurysm	0.000195	0.00032	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTSB—intracranial aneurysm	0.00019	0.000313	CbGpPWpGaD
Nilotinib—LCK—Immune System—NCF1—intracranial aneurysm	0.000189	0.000311	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MMP2—intracranial aneurysm	0.000189	0.00031	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—EDNRA—intracranial aneurysm	0.000187	0.000308	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—EDNRA—intracranial aneurysm	0.000186	0.000305	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—NOS3—intracranial aneurysm	0.000183	0.0003	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—NOS3—intracranial aneurysm	0.000182	0.000299	CbGpPWpGaD
Nilotinib—CA12—Metabolism—NOS3—intracranial aneurysm	0.000181	0.000297	CbGpPWpGaD
Nilotinib—KIT—Immune System—AGER—intracranial aneurysm	0.00018	0.000295	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NCF1—intracranial aneurysm	0.000179	0.000294	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ASAH1—intracranial aneurysm	0.000175	0.000288	CbGpPWpGaD
Nilotinib—LCK—Disease—NCF1—intracranial aneurysm	0.000175	0.000287	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—NOS3—intracranial aneurysm	0.000173	0.000285	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—AGER—intracranial aneurysm	0.00017	0.000279	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NCF1—intracranial aneurysm	0.000169	0.000278	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EDNRA—intracranial aneurysm	0.000169	0.000278	CbGpPWpGaD
Nilotinib—HCK—Disease—NOS3—intracranial aneurysm	0.000163	0.000268	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EDNRA—intracranial aneurysm	0.00016	0.000263	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—AGER—intracranial aneurysm	0.000153	0.000252	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NCF1—intracranial aneurysm	0.000153	0.000251	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000152	0.000251	CbGpPWpGaD
Nilotinib—LYN—Immune System—AGER—intracranial aneurysm	0.00015	0.000246	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—NOS3—intracranial aneurysm	0.00015	0.000246	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—MMP9—intracranial aneurysm	0.000149	0.000246	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NCF1—intracranial aneurysm	0.000149	0.000245	CbGpPWpGaD
Nilotinib—ABL1—Immune System—AGER—intracranial aneurysm	0.000149	0.000245	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—MMP9—intracranial aneurysm	0.000149	0.000244	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EDNRA—intracranial aneurysm	0.000144	0.000237	CbGpPWpGaD
Nilotinib—CA4—Metabolism—NOS3—intracranial aneurysm	0.000144	0.000237	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	0.000144	0.000236	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000142	0.000234	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—AGER—intracranial aneurysm	0.000142	0.000234	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000142	0.000233	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—MMP9—intracranial aneurysm	0.000142	0.000233	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NCF1—intracranial aneurysm	0.000142	0.000233	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EDNRA—intracranial aneurysm	0.000141	0.000232	CbGpPWpGaD
Nilotinib—CA2—Metabolism—NOS3—intracranial aneurysm	0.000138	0.000227	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EDNRA—intracranial aneurysm	0.000134	0.00022	CbGpPWpGaD
Nilotinib—CA1—Metabolism—NOS3—intracranial aneurysm	0.000132	0.000218	CbGpPWpGaD
Nilotinib—LCK—Immune System—AGER—intracranial aneurysm	0.000123	0.000202	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NCF1—intracranial aneurysm	0.000122	0.000201	CbGpPWpGaD
Nilotinib—BRAF—Disease—NOS3—intracranial aneurysm	0.000116	0.000191	CbGpPWpGaD
Nilotinib—CA9—Metabolism—NOS3—intracranial aneurysm	0.000116	0.000191	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CCL2—intracranial aneurysm	0.000116	0.00019	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EDNRA—intracranial aneurysm	0.000116	0.00019	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CCL2—intracranial aneurysm	0.00011	0.000181	CbGpPWpGaD
Nilotinib—KIT—Disease—NOS3—intracranial aneurysm	0.000106	0.000174	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NOS3—intracranial aneurysm	0.000103	0.00017	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NOS3—intracranial aneurysm	0.0001	0.000165	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NOS3—intracranial aneurysm	9.82e-05	0.000161	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	9.39e-05	0.000154	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCL2—intracranial aneurysm	9.23e-05	0.000152	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCL2—intracranial aneurysm	9.15e-05	0.00015	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NOS3—intracranial aneurysm	9.04e-05	0.000149	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCL2—intracranial aneurysm	8.33e-05	0.000137	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—MMP9—intracranial aneurysm	8.29e-05	0.000136	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NOS3—intracranial aneurysm	8.23e-05	0.000135	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NOS3—intracranial aneurysm	8.15e-05	0.000134	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCL2—intracranial aneurysm	7.88e-05	0.00013	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—MMP9—intracranial aneurysm	7.88e-05	0.000129	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NOS3—intracranial aneurysm	7.42e-05	0.000122	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS3—intracranial aneurysm	7.25e-05	0.000119	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCL2—intracranial aneurysm	7.1e-05	0.000117	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOS3—intracranial aneurysm	7.02e-05	0.000115	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCL2—intracranial aneurysm	6.95e-05	0.000114	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NOS3—intracranial aneurysm	6.93e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—MMP9—intracranial aneurysm	6.6e-05	0.000109	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCL2—intracranial aneurysm	6.59e-05	0.000108	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—MMP9—intracranial aneurysm	6.54e-05	0.000107	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOS3—intracranial aneurysm	6.33e-05	0.000104	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOS3—intracranial aneurysm	6.2e-05	0.000102	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MMP9—intracranial aneurysm	5.95e-05	9.78e-05	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NOS3—intracranial aneurysm	5.88e-05	9.67e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOS3—intracranial aneurysm	5.87e-05	9.65e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCL2—intracranial aneurysm	5.7e-05	9.36e-05	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MMP9—intracranial aneurysm	5.64e-05	9.26e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOS3—intracranial aneurysm	5.08e-05	8.35e-05	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MMP9—intracranial aneurysm	5.08e-05	8.34e-05	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—intracranial aneurysm	4.97e-05	8.17e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—intracranial aneurysm	4.71e-05	7.74e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NOS3—intracranial aneurysm	4.31e-05	7.09e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—intracranial aneurysm	4.07e-05	6.7e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NOS3—intracranial aneurysm	3.65e-05	6e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NOS3—intracranial aneurysm	3.18e-05	5.23e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NOS3—intracranial aneurysm	3e-05	4.93e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NOS3—intracranial aneurysm	2.97e-05	4.88e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	1.96e-05	3.22e-05	CbGpPWpGaD
